Indian pharma heirs are building proprietary luxury empires across GCC real estate

A structural shift from passive allocation to principal-level ownership

The Gulf Cooperation Council's real estate market, valued at USD 141.2 billion in 2025 according to IMARC Group, has long attracted global capital seeking yield, residency, and portfolio diversification. Yet the most consequential transformation underway involves a specific capital origin story: Indian pharmaceutical and healthcare dynasties transitioning from passive investors to direct principals in GCC luxury property.

Rishad Poonawalla, scion of the Poonawalla family behind the Serum Institute of India, exemplifies this evolution. As Executive Vice President at Shamal Holding, the entity behind the Baccarat Hotel & Residences Dubai, Poonawalla occupies a position that signals far more than inherited wealth seeking a parking spot in Gulf real estate. His role represents an operational thesis, one where pharma-origin capital moves into proprietorship of trophy hospitality and branded residential assets.

This pattern is neither isolated nor accidental. It reflects a generational recalibration of how India's wealthiest families deploy capital abroad, and the GCC is the primary theatre.

Why are Indian pharma dynasties choosing direct GCC real estate ownership over fund structures?

The traditional playbook for ultra-high-net-worth Indian families entering foreign real estate involved allocating capital through wealth managers, co-investment vehicles, or listed REITs. The current generation has abandoned that model in favour of proprietary portfolio construction.

The reasoning is structural. First, branded residences and luxury hospitality assets in the GCC offer a combination of capital appreciation, operating income, and brand association that passive fund exposure cannot replicate. A principal holding a Baccarat-branded asset in Dubai controls the narrative around that asset, from positioning to exit timing, in a way a limited partner never could.

Second, the regulatory environment has become increasingly accommodating. The Dubai Land Department removed the AED 750,000 minimum property value requirement for the two-year property-linked residency visa in April 2026, eliminating a threshold that, while modest for UHNWIs, symbolised a gatekeeping mechanism. Federal Decree-Law No. 25 of 2025, the New Civil Code, broadened the definition of sale to include digital assets and financial rights while modernising ownership transfer mechanisms, providing greater legal clarity for complex deal architectures.

These regulatory shifts reinforce a broader message: the GCC wants principal-level capital, and it is willing to modernise its legal infrastructure to attract it.

Rishad Poonawalla's position at Shamal Holding illustrates the operational end of this thesis. The Baccarat Hotel & Residences Dubai is a trophy asset that sits at the intersection of ultra-luxury hospitality and branded residential, a category that commands premium pricing and attracts a buyer profile aligned with pharma-dynasty capital: discreet, long-horizon, and brand-conscious.

The broader Poonawalla family's wealth, rooted in vaccine manufacturing and financial services, provides patient capital with minimal pressure for short-cycle returns. This allows for the kind of asset holding period and operational investment that trophy hospitality demands. It is a fundamentally different capital profile from the leveraged developer or the yield-hunting institutional fund.

How are other Indian next-generation principals shaping GCC luxury markets?

Poonawalla is part of a cohort, not an outlier. Several Indian next-generation principals are establishing direct positions across GCC luxury real estate, each with a distinct thesis and vehicle structure.

Avyay Jhunjhunwala, founder of Enzo Developers, represents the developer-principal model. Rather than acquiring existing assets, Jhunjhunwala has built a luxury real estate development firm operating directly in Dubai, executing bespoke projects that target the ultra-luxury segment. The firm's positioning reflects a conviction that Indian principals can compete on product quality and design sensibility in a market historically dominated by Emirati and international developers.

On the institutional capital side, Dr. Amit Goenka, Founder and Chairman of Nisus Finance, expanded the firm's UAE footprint with an INR 247 crore (AED 100 million) investment in residential apartments at Majan, Dubai, according to BSE filings from February 2026. This represents a different entry vector, structured institutional capital with identifiable Indian leadership, deployed into Dubai's residential growth corridors. Where Poonawalla and Jhunjhunwala operate as direct principals, Goenka channels Indian institutional capital through a regulated fund vehicle.

The executive talent pipeline reinforces the thesis. Pawan Chindalia was appointed Group Head of Finance at Emaar Properties, one of the GCC's largest developers, following the departure of Hesham Heikal. While Chindalia's role is corporate rather than principal-level, it signals the depth of Indian executive integration into GCC real estate's institutional core.

Taken together, these positions map a spectrum of Indian capital engagement in GCC luxury real estate: from direct asset ownership (Poonawalla), to ground-up development (Jhunjhunwala), to institutional fund deployment (Goenka), to C-suite operational leadership at major developers (Chindalia).

What does the scale of Indian capital in Dubai real estate reveal about this trend?

The individual narratives gain force when placed against aggregate data. Indian buyers accounted for 23% of foreign residential transactions in Dubai in 2025, purchasing homes worth an estimated ₹85,000 crore to ₹95,000 crore, according to Anarock Property Consultants as reported by The Economic Times. Dubai's total real estate market recorded more than 270,000 transactions worth AED 917 billion in 2025, per the Dubai Land Department.

Indian capital is the single largest foreign-origin flow into Dubai residential property. The pharma-dynasty segment represents the apex of this capital stack, distinguished by deal size, asset class preference, and holding period. While the aggregate Indian buyer base includes mid-market purchasers seeking residency and rental yield, the principal-level players profiled here operate in a fundamentally different stratum: branded residences, trophy hospitality, and bespoke development.

The GCC real estate market is projected to reach USD 260.3 billion by 2034, exhibiting a CAGR of 7.03% from 2026 to 2034, according to IMARC Group. Regional residential supply is expected to increase from approximately 6.26 million units in 2025 to 7.28 million units by 2030, per Alpen Capital. Within this expanding supply envelope, the ultra-luxury and branded-residence segment commands disproportionate capital allocation from Indian pharma and healthcare dynasties.

The regulatory environment continues to evolve in ways that favour this capital. Law No. (4) of 2026, issued by the Ruler of Dubai, regulates shared housing with clear rules for property owners, tenants, and managing companies. While aimed at preventing overcrowding, the law also signals regulatory maturity in property governance, a factor that institutional and principal-level investors weigh heavily.

The portfolio construction logic

The most significant insight from mapping these positions is the portfolio construction logic that emerges. Indian pharma-dynasty principals are building diversified GCC real estate portfolios that combine operating assets (hotels and branded residences), development platforms (bespoke luxury projects), and structured investment vehicles (regulated fund deployments).

This mirrors the approach of established global real estate families, such as Middle Eastern sovereign-linked family offices or European industrial dynasties, that have long maintained proprietary real estate portfolios across multiple geographies and asset classes. The Indian pharma cohort is replicating this model in the GCC with a speed and scale that reflects both the velocity of Indian wealth creation and the GCC's openness to foreign principal capital.

Pharma-origin wealth is particularly well-suited to luxury real estate ownership. The capital is generated by businesses with high margins, recurring revenue, and defensive demand characteristics. These attributes translate into patient, low-leverage capital that can absorb the illiquidity premium inherent in trophy assets.

Strategic implications for GCC real estate leaders

For developers, operators, and capital allocators across the GCC, the rise of Indian pharma-dynasty principals creates both competitive pressure and partnership opportunity. These principals bring proprietary capital, brand sensitivity, and a willingness to take operational roles, qualities that make them attractive joint venture partners for regional players seeking to develop or reposition ultra-luxury assets.

GRI Institute's research and member community have tracked the deepening integration of Indian principal capital into GCC real estate markets through dedicated coverage, member engagement, and strategic convenings. The profiles of principals like Rishad Poonawalla, Avyay Jhunjhunwala, and Dr. Amit Goenka reflect a trend that GRI Institute members across the Gulf have identified as one of the most consequential capital-origin shifts in the region's luxury real estate segment.

The next generation of Indian pharma heirs is building something more durable than a portfolio. They are constructing a permanent capital presence in the GCC's most prestigious asset class, and in doing so, reshaping the competitive landscape for luxury real estate across the Gulf.